STOCK TITAN

Tenax Therapeutics, Inc. (TENX) EPS by Year

TENX

Tenax Therapeutics, Inc. lost $1.34 per diluted share in fiscal year 2025. The table below carries 15 fiscal years, from 2012 to 2025, and the quarters Tenax Therapeutics, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$1.34
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TENX EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1510-KFY1410-KFY1310-KFY1210-K
EPS (Diluted)-$1.34-$1.15-$31.04N/AN/AN/AN/AN/AN/AN/AN/A-$0.50-$2.71-$6.68+52.5%-$14.07

TENX EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.35-$0.35-$0.38-$0.40-$0.27-$0.28$0.22-$0.19-$1.83-$3.12N/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Tenax Therapeutics, Inc. financials

Frequently Asked Questions

What was Tenax Therapeutics, Inc.'s diluted earnings per share in fiscal year 2025?

Tenax Therapeutics, Inc. lost $1.34 per diluted share in fiscal year 2025.

How has Tenax Therapeutics, Inc.'s diluted earnings per share changed over the years?

Across the 15 fiscal years this page covers, Tenax Therapeutics, Inc. (TENX) diluted earnings per share went from -$14.07 in fiscal year 2012 to -$1.34 in fiscal year 2025.

What was Tenax Therapeutics, Inc.'s diluted earnings per share in the most recent quarter?

Tenax Therapeutics, Inc. (TENX) reported -$0.35 in diluted earnings per share in Q2 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Tenax Therapeutics, Inc. (TENX) reported on that line in every period on record.